STOCK TITAN

Twist Bioscience insider sold 9,242 shares for $306,353 in prior quarter

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience Corp (TWST) insider filing reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $93,450, and an approximate sale date of 10/08/2025 on NASDAQ. The shares were acquired on 10/01/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed three prior open-market sales during the past three months totaling 9,242 shares for gross proceeds of $306,353.08 (sales on 07/09/2025, 08/21/2025, and 10/06/2025). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Positive

  • Vested shares (3,000) were received as compensation on 10/01/2025
  • Sales were executed through a registered broker (Fidelity Brokerage Services LLC) on a major exchange (NASDAQ)

Negative

  • Insider sold 9,242 shares in the past three months for $306,353.08, increasing near-term share supply
  • Planned sale of 3,000 vested shares on 10/08/2025 could further increase available shares

Insights

Insider sold 9,242 shares recently and plans to sell 3,000 vested shares on 10/08/2025.

The filing shows a planned sale of 3,000 shares valued at $93,450, acquired by restricted stock vesting on 10/01/2025. Recent open-market dispositions total 9,242 shares for $306,353.08, indicating the insider has been converting equity compensation to cash over the past quarter.

This pattern increases share supply from an insider in the near term and may modestly affect free‑float dynamics; monitor trading around 10/08/2025 and subsequent filings for additional disposals within the reporting window.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the TWST Form 144 disclose about the proposed sale?

The filing reports a proposed sale of 3,000 common shares valued at $93,450, with an approximate sale date of 10/08/2025 on NASDAQ.

How were the 3,000 shares acquired for TWST?

The shares were acquired on 10/01/2025 by restricted stock vesting and the payment was for compensation.

How many TWST shares did the insider sell in the past three months?

The filer sold a total of 9,242 shares on 07/09/2025, 08/21/2025, and 10/06/2025, for gross proceeds of $306,353.08.

Which broker will handle the proposed TWST sale?

The proposed sale lists Fidelity Brokerage Services LLC (address: 900 Salem Street, Smithfield, RI) as the broker.

Does the filer assert possession of undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.67B
60.26M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO